These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6775821)

  • 1. Pretreatment of P815 mastocytoma cells with inhibitors of protein synthesis reduces their susceptibility to lysis by cytotoxic thymus-derived lymphocytes.
    D'Angeac AD; Hale AH
    Cell Immunol; 1980 Oct; 55(2):342-54. PubMed ID: 6775821
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytotoxic T cell responses to a syngeneic tumour: conditions for primary activation in vitro.
    Warren HS; Woolnough JA; Lafferty KJ
    Aust J Exp Biol Med Sci; 1978 Apr; 56(2):247-51. PubMed ID: 98140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysis of enucleated tumor cells with allogeneic and syngeneic cytotoxic thymus-derived lymphocytes.
    Hale AH; Paulus LK
    Eur J Immunol; 1979 Aug; 9(8):640-6. PubMed ID: 227696
    [No Abstract]   [Full Text] [Related]  

  • 4. Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes.
    Waterfield JD; Nixon DF; Mair MG
    Immunology; 1981 Dec; 44(4):685-93. PubMed ID: 6797935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis.
    Boon T; Van Snick J; Van Pel A; Uyttenhove C; Marchand M
    J Exp Med; 1980 Nov; 152(5):1184-93. PubMed ID: 6776227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly-L-lysine-induced immobilization of tumor cells to plastic for the study of cellular metabolic responses to attack by cytotoxic T lymphocytes.
    Sepulveda CA; Schlager SI
    Methods Enzymol; 1983; 93():260-70. PubMed ID: 6408348
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. IV. Analysis of variant-specific antigens by selection of antigen-loss variants with cytolytic T cell clones.
    Maryanski JL; Boon T
    Eur J Immunol; 1982 May; 12(5):406-12. PubMed ID: 6178608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of hydrogen peroxide in the cytotoxic reaction of T lymphocytes.
    Thorne KJ; Svvennsen RJ; Franks D
    Clin Exp Immunol; 1980 Feb; 39(2):486-95. PubMed ID: 6248285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyte.
    Frassanito MA; Mayordomo JI; DeLeo RM; Storkus WJ; Lotze MT; DeLeo AB
    Cancer Res; 1995 Jan; 55(1):124-8. PubMed ID: 7528638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive growth of immunogenic tumors: relationship between susceptibility of ascites P815 tumor cells to T-cell-mediated lysis and immune destruction in vivo.
    Fahey JR; Hines DL
    Cancer Res; 1987 Sep; 47(18):4759-65. PubMed ID: 3113723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P815 mastocytoma cells, classical targets for cytotoxic T lymphocytes, exert natural cytotoxicity.
    Luciani MF; Brunet JF; Denizot F; Golstein P
    Ann Inst Pasteur Immunol; 1987; 138(1):37-43. PubMed ID: 3107589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enucleated target cells are susceptible to lymphocyte-mediated cytolysis.
    Court WS; Lindquist RR
    Transplantation; 1979 Oct; 28(4):351-3. PubMed ID: 116402
    [No Abstract]   [Full Text] [Related]  

  • 13. [Humoral mechanisms of in vitro inhibition of mouse lymphocyte immunoreactivity by mastocytoma P815 cells].
    Medvedev AE
    Biull Eksp Biol Med; 1988 Jun; 105(6):701-3. PubMed ID: 2968820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific reversal of cytolytic T lymphocyte--target cell interaction.
    Balk SP; Mescher MF
    J Supramol Struct Cell Biochem; 1981; 16(1):43-52. PubMed ID: 6795359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The blocking activity of antisera raised to either tumor antigens or alloantigens in cytotoxicity assays using syngeneic or allogeneic killer cells on the P815 murine mastocytoma target.
    Al-Rammahy AK; Levy JG
    Cell Immunol; 1980 Dec; 56(2):338-46. PubMed ID: 6781763
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice.
    Uyttenhove C; Van Snick J; Boon T
    J Exp Med; 1980 Nov; 152(5):1175-83. PubMed ID: 6776226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high frequency of cytotoxic precursor cells for a syngeneic tumour.
    Warren HS; Lafferty KJ
    Scand J Immunol; 1979; 10(4):349-52. PubMed ID: 119310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spin labeling studies of the interactions of P815 mouse mastocytoma cells with antiserum to histocompatibility antigens, H-2d.
    Merritt MV; Loughman E
    Immunopharmacology; 1979 Jul; 1(4):301-14. PubMed ID: 95572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of cytotoxic mechanisms induced by minor histocompatibility antigens in the mouse.
    Jones B
    Cell Immunol; 1978 Jun; 38(1):157-67. PubMed ID: 96941
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumour-associated antigens of the mouse P-815 mastocytoma cell: evidence for an antigen with H-2-like characteristics.
    Clemetson KJ; Bertschmann M; Lüscher EF
    Mol Immunol; 1981 Feb; 18(2):135-41. PubMed ID: 6167852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.